Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies. Issue 3 (23rd March 2023)
- Record Type:
- Journal Article
- Title:
- Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies. Issue 3 (23rd March 2023)
- Main Title:
- Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies
- Authors:
- Qing, Yingjie
Guo, Yongjian
Zhao, Qinwen
Hu, Po
Li, Hui
Yu, Xiaoxuan
Zhu, Mengyuan
Wang, Hongzheng
Wang, Zhanyu
Xu, Jingyan
Guo, Qinglong
Hui, Hui - Abstract:
- Abstract: Background: T cell malignancies proliferate vigorously, are highly dependent on lysosomal function, with limited therapeutic options. Deregulation of lysosomal structure and function has been confirmed to be a key role in the treatment of hematologic malignant disease. Methods: Cell counting kit 8 and Annexin V/PI staining were used to assess the cell viability and apoptosis rate. Flow cytometry, liquid chromatography mass spectrometry, immunofluorescence and western blot were performed to detect the effect on lysosomes. Drug affinity responsive target stability, molecular docking and cellular thermal shift assay were employed to confirm the target protein of V8 on lysosomes. A xenograft model was constructed in NOD/SCID mice to assess the effect and mechanism. Results: V8, a new lysosomotropic compound, could be rapidly trapped by lysosomes and accumulation in lysosomes, contributing to lysosomal‐dependent cell death by evoking lysosomal membrane permeabilization (LMP), accompanied with disrupted lysosome and autophagic flux. Mechanistically, heat shock protein 70 (HSP70) was identified as the binding target of V8 in lysosome. As a downstream effect of targeting HSP70, enzymatic activity of acid sphingomyelinase (ASM) was inhibited, which induced disturbance of lipid metabolism, instability of lysosomal membrane, and leakage of cathepsin B and D, leading to LMP‐mediated cell death. In vivo study showed V8 well controlled the growth of the tumour and confirmedAbstract: Background: T cell malignancies proliferate vigorously, are highly dependent on lysosomal function, with limited therapeutic options. Deregulation of lysosomal structure and function has been confirmed to be a key role in the treatment of hematologic malignant disease. Methods: Cell counting kit 8 and Annexin V/PI staining were used to assess the cell viability and apoptosis rate. Flow cytometry, liquid chromatography mass spectrometry, immunofluorescence and western blot were performed to detect the effect on lysosomes. Drug affinity responsive target stability, molecular docking and cellular thermal shift assay were employed to confirm the target protein of V8 on lysosomes. A xenograft model was constructed in NOD/SCID mice to assess the effect and mechanism. Results: V8, a new lysosomotropic compound, could be rapidly trapped by lysosomes and accumulation in lysosomes, contributing to lysosomal‐dependent cell death by evoking lysosomal membrane permeabilization (LMP), accompanied with disrupted lysosome and autophagic flux. Mechanistically, heat shock protein 70 (HSP70) was identified as the binding target of V8 in lysosome. As a downstream effect of targeting HSP70, enzymatic activity of acid sphingomyelinase (ASM) was inhibited, which induced disturbance of lipid metabolism, instability of lysosomal membrane, and leakage of cathepsin B and D, leading to LMP‐mediated cell death. In vivo study showed V8 well controlled the growth of the tumour and confirmed lysosomal cell death induced by V8. Conclusions: Collectively, this study suggests targeting lysosomal HSP70‐ASM axis by V8 illustrates the great value of drug therapy for T cell malignancies and the unlimited potential of lysosomal targeting for cancer therapy. Abstract : Find a new lysosomotropic drug V8. The characteristics of targeting lysosome HSP70 are clarified. Disturbance of lysosomal lipid metabolism is a new approach for T cell malignancies. The HSP70‐ASM axis regulates lysosomal stability. … (more)
- Is Part Of:
- Clinical and translational medicine. Volume 13:Issue 3(2023)
- Journal:
- Clinical and translational medicine
- Issue:
- Volume 13:Issue 3(2023)
- Issue Display:
- Volume 13, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 13
- Issue:
- 3
- Issue Sort Value:
- 2023-0013-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2023-03-23
- Subjects:
- acid sphingomyelinase -- heat shock protein 70 -- lipid metabolism -- lysosomal membrane permeabilization -- lysosome -- T cell malignancies
Clinical medicine -- Periodicals
Medicine, Experimental -- Periodicals
Medical innovations -- Periodicals
Molecular biology -- Periodicals
Pathology, Molecular -- Periodicals
616.027 - Journal URLs:
- https://onlinelibrary.wiley.com/loi/20011326 ↗
http://www.clintransmed.com/content ↗
http://www.biomedcentral.com/journals/#C ↗
http://www.springer.com/gb/ ↗ - DOI:
- 10.1002/ctm2.1229 ↗
- Languages:
- English
- ISSNs:
- 2001-1326
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26929.xml